607 related articles for article (PubMed ID: 28267267)
1. Peripheral neuropathy in prediabetes and the metabolic syndrome.
Stino AM; Smith AG
J Diabetes Investig; 2017 Sep; 8(5):646-655. PubMed ID: 28267267
[TBL] [Abstract][Full Text] [Related]
2. Metabolic syndrome and peripheral neuropathy.
Kazamel M; Stino AM; Smith AG
Muscle Nerve; 2021 Mar; 63(3):285-293. PubMed ID: 33098165
[TBL] [Abstract][Full Text] [Related]
3. Diabetes and Peripheral Nerve Disease.
Zilliox LA
Clin Geriatr Med; 2021 May; 37(2):253-267. PubMed ID: 33858608
[TBL] [Abstract][Full Text] [Related]
4. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.
Tentolouris A; Eleftheriadou I; Grigoropoulou P; Kokkinos A; Siasos G; Ntanasis-Stathopoulos I; Tentolouris N
J Diabetes Complications; 2017 Nov; 31(11):1624-1629. PubMed ID: 28893495
[TBL] [Abstract][Full Text] [Related]
5. Effect of lifestyle interventions on diabetic peripheral neuropathy in patients with type 2 diabetes, result of a randomized clinical trial.
Ghavami H; Radfar M; Soheily S; Shamsi SA; Khalkhali HR
Agri; 2018 Oct; 30(4):165-170. PubMed ID: 30403270
[TBL] [Abstract][Full Text] [Related]
6. Exercise as Treatment for Neuropathy in the Setting of Diabetes and Prediabetic Metabolic Syndrome: A Review of Animal Models and Human Trials.
Singleton JR; Foster-Palmer S; Marcus RL
Curr Diabetes Rev; 2022; 18(5):e230921196752. PubMed ID: 34561989
[TBL] [Abstract][Full Text] [Related]
7. Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE Cohort.
Lee CC; Perkins BA; Kayaniyil S; Harris SB; Retnakaran R; Gerstein HC; Zinman B; Hanley AJ
Diabetes Care; 2015 May; 38(5):793-800. PubMed ID: 25665810
[TBL] [Abstract][Full Text] [Related]
8. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments.
Elafros MA; Andersen H; Bennett DL; Savelieff MG; Viswanathan V; Callaghan BC; Feldman EL
Lancet Neurol; 2022 Oct; 21(10):922-936. PubMed ID: 36115364
[TBL] [Abstract][Full Text] [Related]
9. Emerging Nonpharmacologic Interventions to Treat Diabetic Peripheral Neuropathy.
Enders J; Elliott D; Wright DE
Antioxid Redox Signal; 2023 May; 38(13-15):989-1000. PubMed ID: 36503268
[No Abstract] [Full Text] [Related]
10. Neuropathy associated with prediabetes: what is new in 2007?
Singleton JR; Smith AG
Curr Diab Rep; 2007 Dec; 7(6):420-4. PubMed ID: 18255003
[TBL] [Abstract][Full Text] [Related]
11. Impaired rate-dependent depression of the H-reflex in type-2 diabetes, prediabetes, overweight and obesity: A cross-sectional study.
Salinas LF; Trujillo-Condes VE; Tecuatl C; Delgado-Lezama R; Cuellar CA
Medicine (Baltimore); 2022 Oct; 101(43):e31046. PubMed ID: 36316945
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and risk factors for diabetic peripheral neuropathy, neuropathic pain and foot ulceration in the Arabian Gulf region.
Ponirakis G; Elhadd T; Al Ozairi E; Brema I; Chinnaiyan S; Taghadom E; Al Kandari J; Al Wotayan R; Al Ozairi A; Aljohani N; AlMistehi W; Al Qahtani N; Khan S; Dabbous Z; Siddique MA; Petropoulos IN; Khan A; Almuhannadi H; Ashawesh KA; Dukhan KM; Mahfoud ZR; Zirie MA; Jayyousi A; Malik RA
J Diabetes Investig; 2022 Sep; 13(9):1551-1559. PubMed ID: 35445568
[TBL] [Abstract][Full Text] [Related]
13. Mediators of diabetic neuropathy: is hyperglycemia the only culprit?
Grisold A; Callaghan BC; Feldman EL
Curr Opin Endocrinol Diabetes Obes; 2017 Apr; 24(2):103-111. PubMed ID: 28098594
[TBL] [Abstract][Full Text] [Related]
14. The prevalence and associated risk factors of peripheral diabetic neuropathy in Hamedan, Iran.
Kiani J; Moghimbeigi A; Azizkhani H; Kosarifard S
Arch Iran Med; 2013 Jan; 16(1):17-9. PubMed ID: 23273229
[TBL] [Abstract][Full Text] [Related]
15. Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study.
Baltzis D; Roustit M; Grammatikopoulou MG; Katsaboukas D; Athanasiou V; Iakovou I; Veves A; Manes C; Trakatelli MC
Adv Ther; 2016 Oct; 33(10):1840-1847. PubMed ID: 27554090
[TBL] [Abstract][Full Text] [Related]
16. Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.
Smith AG; Singleton JR; Aperghis A; Coffey CS; Creigh P; Cudkowicz M; Conwit R; Ecklund D; Fedler JK; Gudjonsdottir A; Hauer P; Herrmann DN; Kearney M; Kissel J; Klingner E; Quick A; Revere C; Stino A;
JAMA Neurol; 2023 Dec; 80(12):1334-1343. PubMed ID: 37870862
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic neuropathy, prediabetes and the metabolic syndrome.
Gordon Smith A; Robinson Singleton J
J Neurol Sci; 2006 Mar; 242(1-2):9-14. PubMed ID: 16448668
[TBL] [Abstract][Full Text] [Related]
18. Diabetic neuropathy and painful diabetic neuropathy: Cinderella complications in South East Asia.
Almuhannadi H; Ponirakis G; Khan A; Malik RA
J Pak Med Assoc; 2018 Jan; 68(1):85-89. PubMed ID: 29371725
[TBL] [Abstract][Full Text] [Related]
19. Mouse models of diabetic neuropathy.
O'Brien PD; Sakowski SA; Feldman EL
ILAR J; 2014; 54(3):259-72. PubMed ID: 24615439
[TBL] [Abstract][Full Text] [Related]
20. No clear evidence of neuropathy among patients with high risk for the development of prediabetes/diabetes-a pilot study.
Körei AE; Békeffy M; Menyhárt A; Osgyán K; Istenes I; Horváth VJ; Kempler P
Front Endocrinol (Lausanne); 2024; 15():1302013. PubMed ID: 38352713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
